Fitbit Collaborates with BMS-Pfizer Alliance Focusing on Improving Atrial Fibrillation Detection

 Fitbit Collaborates with BMS-Pfizer Alliance Focusing on Improving Atrial Fibrillation Detection

Fitbit Collaborates with BMS-Pfizer Alliance Focusing on Improving Atrial Fibrillation Detection

Shots:

  • The BMS-Pfizer Alliance and Fitbit collaborate to develop educational content and guidance, supporting patients with a high risk of AFib. The companies will focus on providing information to encourage patients to have a discussion with their physicians, following the FDA clearance of AFib detection software on Fitbit devices
  • The collaboration helps to bridge the gaps existing in AFib detection and reducing risk of stroke with its 24/7 on-wrist health tracking capabilities and experience of delivering personalized, engaging software and services
  • Fitbit’s wearable technology provide motivation for everyday health and fitness and includes products like Fitbit Charge 3, Fitbit Inspire HR, Fitbit Inspire, Fitbit Ace 2 activity trackers, as well as the Fitbit Ionic & Fitbit Versa smartwatches, Fitbit Flyer wireless headphones & Fitbit Aria family of smart scales

Click here to­ read full press release/ article | Ref: BMS | Image: Amazon

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post